Authors:
Akunne, HC
Zoski, KT
Davis, MD
Cooke, LW
Meltzer, LT
Whetzel, SZ
Shih, YH
Wustrow, DJ
Wise, LD
MacKenzie, RG
Georgic, LM
Heffner, TG
Pugsley, TA
Citation: Hc. Akunne et al., PD 158771, a potential antipsychotic agent with D-2/D-3 partial agonist and 5-HT1A agonist actions. I. Neurochemical effects, NEUROPHARM, 39(7), 2000, pp. 1197-1210
Authors:
Corbin, AE
Meltzer, LT
Ninteman, FW
Wiley, JN
Cristoffersen, CL
Wustrow, DJ
Wise, LD
Pugsley, TA
Heffner, TG
Citation: Ae. Corbin et al., PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. II. Preclinical behavioral effects, NEUROPHARM, 39(7), 2000, pp. 1211-1221
Citation: D. Feifel et al., Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist, J PHARM EXP, 288(2), 1999, pp. 710-713
Authors:
Belliotti, TR
Wustrow, DJ
Brink, WA
Zoski, KT
Shih, YH
Whetzel, SZ
Georgic, LM
Corbin, AE
Akunne, HC
Heffner, TG
Pugsley, TA
Wise, LD
Citation: Tr. Belliotti et al., A series of 6-and 7-piperazinyl- and -piperidinylmethylbenzoxazinones withdopamine D4 antagonist activity: Discovery of a potential atypical antipsychotic agent, J MED CHEM, 42(25), 1999, pp. 5181-5187